Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
American Journal of Human Genetics|April 28, 2006
Quantification of homozygosity in consanguineous individuals with autosomal recessive diseaseC Geoffrey Woods, James Cox, Kelly Springell, et al.
Nature Communications|January 27, 2025
Genetic coupling of enhancer activity and connectivity in gene expression controlHelen Ray-Jones, Chak Kei Sung, Lai Ting Chan, et al.
BMC Genomics|April 12, 2014
A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samplesNikolas Pontikos, Deborah J Smyth, Helen Schuilenburg, et al.
Journal of Hypertension|June 14, 2008
Glutathione S-transferase variants and hypertensionChristian Delles, Sandosh Padmanabhan, Wai Kwong Lee, et al.
Neurology|April 27, 2018
ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer diseaseJeffrey L Cummings, Sharon Cohen, Christopher H van Dyck, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
Plos Genetics|June 25, 2015
Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine MappingChris Wallace, Antony J Cutler, Nikolas Pontikos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid SyndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
Journal of Autoimmunity|July 28, 2017
Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunityRicardo C Ferreira, Henry Z Simons, Whitney S Thompson, et al.
Alzheimer'S Research & Therapy|September 21, 2018
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)Stephen Salloway, Lee A Honigberg, William Cho, et al.
Pageof 20